lupus.bmj2d
Glucocorticoid discontinuation in patients with SLE with prior severe organ involvement: a single-center retrospective analysis
Objective Long-term glucocorticoid use in SLE may have significant side effects; however, glucocorticoid discontinuation is occasionally associated with disease flare-ups. Therefore, we evaluated the ...
lupus.bmj4d
VPS13C and STING expression in neuropsychiatric systemic lupus erythematosus: unveiling an unbreached territory
Objectives To measure the expression level of the vacuolar protein sorting 13 (VPS13) gene and stimulator of interferon genes (STING) in patients with SLE with and without reported neuropsychiatric ...
lupus.bmj6d
Characterisation and outcomes of different subsets of low disease activity states in patients with systemic lupus erythematosus
Objectives The lupus low disease activity state (LLDAS) allows for certain clinical and/or serological activity of SLE, provided overall disease activity does not exceed predefined cut-offs. This ...
lupus.bmj6d
LP-091 Neutrophil extracellular traps in APS and SLE
1 Laboratory of Thromboinflammation, Nasonova Research Institute of Rheumatology, Russian Federation 2 Laboratories of biomedical research methods, Moscow Regional Clinical Research Institute named ...